To systematically examine the relative magnitude and predictors of responses to exercise training in older adult with heart failure (HF) with reduced ejection fraction (HFrEF), and preserved EF (HFpEF). DESIGN: Secondary analysis of a randomized controlled trial. SETTING: Outpatient cardiac rehabilitation program. PARTICIPANTS: Individuals with HF (24 HFrEF, 24 HFpEF) who underwent supervised exercise training. MEASUREMENTS: The study included individual-level data from the exercise training arms of a randomized controlled trial that evaluated the effect of 16 weeks of supervised moderate-intensity endurance exercise training in older adults with chronic, stable HFpEF and HFrEF. Changes in peak oxygen uptake (VO 2peak ) in response to supervised training in individuals with HFpEF were compared with that of individuals with HFrEF. The significant clinical predictors of changes in VO 2peak with exercise training were assessed using univariate and multivariate regression models. RESULTS: Training-related improvement in VO 2peak was higher in participants with HFpEF than in those with HFrEF (change: 18.7 AE 17.6% vs À0.3 AE 15.4%, P < .001). In univariate analysis, echocardiographic abnormalities in left ventricular structure and function and lower body mass index were associated with blunted response of VO 2peak with exercise training. In multivariate regression analysis using stepwise selection, submaximal exercise systolic blood pressure, and resting early deceleration time were independent predictors of change in VO 2peak . CONCLUSION: The change in VO 2peak in response to endurance exercise training in older adults with HF differs significantly according to HF subtype, with greater VO 2peak improvement in HFpEF than HFrEF. These results suggest that the current Centers for Medicare and Medicaid Services policy excluding individuals with HFpEF from reimbursement from cardiac rehabilitation may need to be revisited.
H eart failure (HF) is associated with high morbidity and mortality, poor quality of life, and high cost of care. 1, 2 It is particularly common in older adults, in whom its prevalence is growing and is the leading cause of hospitalization. 3, 4 Exercise intolerance, measured objectively as low peak exercise oxygen uptake (VO 2peak ), is the primary manifestation of chronic HF and is a strong determinant of prognosis. [5] [6] [7] [8] Multiple studies have shown that exercise training can improve VO 2peak in individuals with HF, but there is less information regarding the effect of exercise training specifically in older adults, and particularly in individuals with HF with preserved ejection fraction (HFpEF), the most common form of HF in older persons.
Previous studies have demonstrated considerable heterogeneity in the response to exercise training in healthy individuals and in individuals with risk factors for HF, [9] [10] [11] [12] but there is little information for older adults with established HF. Furthermore, to the authors' knowledge, the patterns and clinical predictors of response of VO 2peak to training have not been compared in older adults with HFpEF and HFrEF. This is particularly relevant considering the high burden of exercise intolerance and cardiac structural and functional abnormalities in this population, as well as the increasing role of exercise training for management of chronic HF.
Therefore, this study was designed to characterize the variability in VO 2peak response to supervised endurance exercise training in older adults with HFpEF and HFrEF and to determine the significant predictors of VO 2peak change in response to endurance exercise training in individuals with HFpEF and HFrEF.
METHODS

Study Population
Individual-level data from a prospective, randomized, blinded, attention-controlled trial of facility-based, supervised endurance exercise training in individuals aged 65 and older in which randomization was stratified according to EF was examined. [13] [14] [15] Detailed descriptions of the screening, recruitment, inclusion and exclusion criteria, and methods of the trial and the main outcomes of each of the two stratification arms (HFpEF, HFrEF) have been reported previously. 13, 15 Briefly, individuals with chronic, well-compensated HF on a stable medication regimen for 6 weeks or more were recruited from review of inpatient and outpatient records. HF was defined using clinical criteria from National Health and Nutrition Examination Survey and criteria described in a previous study. 16, 17 HFpEF was defined based on presence of clinical HF with preserved ejection fraction (EF >50%) and no evidence of a significant medical condition that could mimic HF symptoms. 13, 14 HFrEF was defined based on presence of clinical HF and reduced ejection fraction (EF <45%). 15 Patients with significant valvular disease, recent stroke or myocardial infarction, uncontrolled diabetes mellitus or hypertension, known cancer diagnosis, significant renal impairment, dementia, nonadherence to therapies, or any chronic condition that limited participation in exercise training were excluded. For the present analysis, which examined training response and its determinants, the two randomized strata (HFpEF and HFrEF) were combined, with each containing two treatment groups: an attention control group and an exercise group. A highly significant interaction was found between treatment group and HF category (P = .006), so all analyses were completed using participants randomized to the exercise groups only. The Wake Forest institutional review board approved the study protocol, and written informed consent was obtained from all study participants.
Cardiopulmonary Exercise Testing
Upright cycle ergometer exercise testing with expired gas-exchange analysis was performed at baseline and follow-up using previously reported protocols. Breath-bybreath gas exchange data were averaged for the last 30 seconds of the exercise test to determine peak values. Ventilatory anaerobic threshold was determined using standardized protocol. A 6-minute walk test was also performed at baseline and end of training period using a standard protocol. 5 As reported previously, the mean respiratory exchange ratio, a measure of exercise effort, was high (>1.1) for the HFpEF and HFrEF groups during baseline and follow-up exercise testing.
13,15
Echocardiographic Examination
Resting two-dimensional and Doppler echocardiographic examination was performed during supine rest as reported previously to obtain standard two-dimensional images in the parasternal long-and short-axis and the apical twoand four-chamber views. 13, 15 Individuals blinded to study group assignment determined left ventricular (LV) volumes using a digital workstation.
Endurance Exercise Training
Training participants underwent supervised exercise training three times per week for 16 weeks, as reported previously. [13] [14] [15] Each exercise training session was 1 hour long and consisted of warm-up, stimulus, and cool-down phases. The stimulus phase included walking on a track and lower extremity cycling, and the exercise intensity was gradually increased from 40% to 50% of heart rate reserve in the first 2 weeks to 60% to 70% over the next several weeks. Duration of exercise in each training mode was also increased gradually to achieve the target duration of 15 to 20 minutes each of walking and cycling. The training protocols used in the HFpEF and HFrEF exercise training groups were identical. 13, 15 As reported previously, adherence to exercise training of individuals with HFpEF and HFrEF was high. In the HFpEF group, participants in the exercise training arm attended an average of 43 of the assigned 48 sessions. 13 Similarly, in the HFrEF group exercise training participants attended an average of 45 sessions. 15 
Statistical Analysis
The primary outcome for assessing change in exercise capacity was percentage change in VO 2peak (mL/kg per minute) from baseline to end of exercise training (16-week follow-up). Mean changes in VO 2peak , exercise time, 6-minute walk distance, and ventilatory anaerobic threshold of the HFpEF and HFrEF groups were compared using the t-test. The proportion of exercising HFpEF and HFrEF participants with 5% and 10% improvement in these measures was also compared using the chi-square test.
Significant clinical predictors of change in VO 2peak with exercise training were assessed using data from both groups. Associations between changes in VO 2peak and dichotomous and categorical ordinal variables were tested using the t-test and trend test, respectively, with mean and standard error of each level given. Associations between changes in VO 2peak and continuous variables were summarized and tested for significance using the correlation coefficient. The test of associations was performed for the overall study population and separately for HFpEF and HFrEF. A test for interaction between HF type and the clinical variables was also performed. A multivariate linear regression model was also constructed using stepwise selection considering all the variables that were significant in univariate analyses. All tests were made at the 5% twosided level of significance.
RESULTS
The study population included 48 individuals with HF (24 HFrEF, 24 HFpEF) who underwent 4 months of supervised exercise training. Table 1 provides the baseline characteristics of the combined study population and for each HF subtype. The groups were well matched on most variables, except for a higher frequency of women in the HFpEF group, as expected based on population demographic characteristics, and EF, by design. More participants with HFrEF had New York Heart Association Class III symptoms than those with HFpEF, but this difference was not statistically significant. Similarly, baseline exercise capacity as assessed using multiple measures was not different between the two groups. Of echocardiographic characteristics, normal diastolic filling pattern was present in 23% of participants with HFpEF. This observation is consistent with those reported in other large randomized controlled trials with individuals with well-characterized HFpEF. [18] [19] [20] Table 2 compares changes in measures of exercise capacity. Overall, in both groups combined, endurance training was associated with 9.2% greater VO 2peak (mL/kg per minute), with substantial individual-level variability in change in response to training (Figure 1 ). Of HF subtypes, improvement in VO 2peak in response to training was considerably higher in participants with HFpEF (18.7 AE 17.6%) than in those with HFrEF (À0.3 AE 15.4%) (P < .001) (Table 2; Figure 2) . A similar pattern was observed with absolute VO 2peak (mL/min, Table 2; Figure 2 ). The proportion of patients with greater than 5% and greater than 10% improvement in VO 2peak (mL/kg per minute) was also significantly higher in participants with HFpEF than in those with HFrEF (75% vs 33.3%, P = .004 for >5% improvement; 66.7% vs 29.2%, P = .009 for >10% improvement). Similar patterns of improvement were also observed in absolute VO 2peak (mL/min) in participants with HFpEF and HFrEF . Training-related increases in other measures of exercise capacity, including exercise time and ventilatory anaerobic threshold, were also numerically greater in participants with HFpEF than in those with HFrEF (Table 2; Figure 2 ). In contrast, change in 6-minute walk distance was not significantly different between the two groups (Table 2; Figure 2) .
Results of the univariate analyses evaluating clinical and demographic predictors of change in VO 2peak with exercise training in all participants, as well as for those with HFpEF and HFrEF are shown in Tables S1 and S2 . For overall HF, higher body mass index was significantly associated with greater improvements in VO 2peak in univariate analyses. Other baseline characteristics such as age, sex, ethnicity, and resting blood pressure were not associated with exercise training-related changes in VO 2peak . Of resting echocardiographic characteristics, smaller LV volumes, higher ejection fraction, lower baseline LV mass, and higher deceleration time were each associated with greater improvements in VO 2peak (Table S3 ). For HF subtypes, no significant interaction was observed between participant characteristics and HF type (HFpEF vs HFrEF) for change in VO 2peak . Thus, different responses in VO 2peak to exercise training of participants with HFpEF and HFrEF were not related to differences in baseline clinical characteristics. In the multivariate linear regression model using stepwise selection for variables shown to be significant in univariate analyses, lower submaximal systolic blood pressure (P = .008) and higher deceleration time (P = .04) were found to be independently associated with greater increase in VO 2peak . Similar results were also observed in sensitivity analysis evaluating the significant clinical predictors of change in absolute VO 2peak (mL/min).
DISCUSSION
Training-related improvement in VO 2peak varied substantially according to HF type, with considerably greater improvements in participants with HFpEF than in those with HFrEF. To the knowledge of the authors, the present study is the first to directly compare, in a single study and with randomized assignment and blinding of outcomes, VO 2peak response to training in older adults with HFpEF and HFrEF and to assess predictors of training response. These results are important because exercise intolerance is the primary symptom of chronic HF, because reduction in exercise capacity is particularly severe in older adults, and because exercise training is one of the few interventions shown to improve this outcome in individuals with HFpEF, the most-common form of HF in older adults. Participants with HFpEF had a greater average increase in VO 2peak , with a higher proportion of clinically meaningful improvement (>5% and >10%), than those with HFrEF. This observation was consistent for different cutoffs for meaningful VO 2peak response despite use of identical exercise training regimens and high rates of adherence in the two groups. The results of Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION), the largest randomized trial of exercise training in individuals with HFrEF, which demonstrated only a 4% increase in VO 2peak after 3 months of supervised exercise training, supports the lack of improvement in VO 2peak with exercise training in older adults with HFrEF. This is less than the 6% to 10% improvement in VO 2peak that is generally accepted as clinically meaningful. This VO 2peak outcome was not blinded in HF-ACTION, and the cohort was considerably younger (mean age 59 vs 69 in the current study population). 21 In contrast to these findings in older adults with HFrEF in the current study and in HF-ACTION, a more-robust and significant improvement in VO 2peak with exercise training was observed in older adults with HFpEF. 22 Patterns of improvement in other objective, independent measures of exercise capacity, including exercise time and ventilatory anaerobic threshold, were similar to those in VO 2peak in individuals with HFpEF and HFrEF, supporting the internal validity of the study findings. Changes in 6-minute walk distance were not significantly different between the two study groups. VO 2peak is a reliable criterion standard measure of maximal exercise capacity and has been demonstrated to have minimal learning effect. 23 In contrast, learning effect from one test to the next may influence other measures such as 6-minute walk distance. Furthermore, participants are not pushed to an exhaustive exercise endpoint in 6-minute walk distance, and variability in speed may significantly influence the outcome.
The potential mechanisms underlying the different VO 2peak improvement between individuals with HFpEF and HFrEF are not well understood. Abnormal LV HF = heart failure; EF = ejection fraction; VO 2 peak = peak oxygen uptake. Figure 1 . Variability in change in relative peak oxygen uptake (VO 2peak ) with exercise training. Percentage change in VO 2peak (mL/kg per minute, y-axis) was calculated in exercise training participants from baseline to follow-up visits. Individual participants are represented on the x-axis in increasing order of VO 2peak change.
remodeling and higher LV mass are associated with blunted VO 2peak response to training. 24 It is possible that individuals with HFrEF with higher burden of LV remodeling may not be able to adapt to exercise as well with favorable physiological changes in cardiac performance. In contrast, up to 40% to 60% of individuals with HFpEF have normal LV structure and cardiac function without LV hypertrophy or abnormal remodeling, which may make them more amenable to the physiological adaptations of exercise training. 20, 25 Similarly, different skeletal muscle response to exercise training may explain some of the observed differences in VO 2peak improvement between individuals with HFpEF and those with HFrEF. 26 Future mechanistic studies are needed to test these hypotheses.
In multivariate regression analysis, submaximal systolic blood pressure and early LV deceleration time were identified as significant independent predictors of VO 2peak improvement with endurance exercise training, such that higher systolic blood pressure and shorter early LV deceleration time were associated with blunted VO 2peak response to training in individuals with HF. Both of these factors may be associated with VO 2 response through their effect on stroke volume reserve.
This study may have clinical implications. Several randomized controlled trials have failed to demonstrate a decrease in mortality in individuals with HFpEF with use of available pharmacological interventions, [27] [28] [29] although some studies have shown improvement in symptoms, decrease in hospitalizations, and improvements in quality of life. [27] [28] [29] [30] Specifically, exercise training has been shown to improve quality of life and possibly to reduce hospitalizations in individuals with HFrEF and HFpEF. 21, 22, 31 Nevertheless, the Center for Medicare and Medicaid Services (CMS) recently approved expansion of coverage for cardiac rehabilitation in individuals with chronic, stable HFrEF but not HFpEF, effectively excluding the majority of older adults with HF. 32 The current study findings provide strong evidence in favor of incorporating cardiac rehabilitation and exercise training as a therapeutic strategy for management of HFpEF, similar to HFrEF, and may help provide impetus for CMS to revise its reimbursement policy.
This study has several strengths. It included only older adults, allowing examination of the relevant hypotheses specifically in this important and previously understudied group with HF. Individuals with HFpEF and HFrEF were enrolled in the trial at the same time, using identical methods, personnel, equipment, and facilities for exercise testing and training, and personnel assessing outcomes were blinded to randomization group, enhancing the validity of intergroup comparisons. The participants were well Figure 2 . Individual-level and mean changes in different measures of (A) exercise capacity (indexed and absolute peak exercise oxygen uptake), (B) exercise time and 6-minute walk distance, and (C) ventilatory anaerobic threshold with exercise training from baseline to follow-up in individuals with heart failure (HF) with preserved ejection fraction (HFpEF) and those with HR with reduced EF (HFrEF).
phenotyped with detailed clinical, echocardiographic, and cardiopulmonary exercise testing.
This study also has several important limitations. First, the training protocol included only continuous, moderateintensity exercise, and the VO 2peak response may be different for other modes or intensity of exercise training. Second, multiple comparisons were not adjusted for, so the findings may be viewed as hypothesis generating in need of confirmation in future studies. Finally, the percentage of beta-blocker use was low in the HFrEF group, probably because the participants were elderly and had multiple comorbidities. In addition, the study was conducted when beta-blockers were in the early phase of becoming standard therapy in individuals with HFrEF, although this supports the findings of a training differential between HFpEF and HFrEF, because the medication profiles were fairly similar between groups.
In conclusion, VO 2peak change in response to supervised moderate-intensity endurance exercise training in older adults with HF varies according to HF subtype, with greater peak VO 2 improvement in individuals with HFpEF than in those with HFrEF. These results suggest that the current CMS policy excluding individuals with HFpEF from reimbursement for cardiac rehabilitation may need to be revisited. Sponsor's Role: None.
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